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Background: Cardiac rehabilitation (CR) has been shown to be an efficacious part of disease 
management to reduce negative outcomes associated with a variety of cardiovascular diseases 
(CVDs).  Despite the significant amount of research support, participation rates in CR programs 
remain suboptimal.  While a plethora of research exists which examines potential reasons for 
the lack of participation, there are still factors which have yet to be fully examined.  For example, 
while depression has been associated with reduced CR participation, this association has not 
been fully explored in the literature and some related psychological factors may also be key 
contributors to the lack of participation in CR. 
Purpose: The current research seeks to explore the impact of depression and related 
psychosocial variables on CR participation.  By examining specific symptom clusters of 
depression and related variables, such as negative illness cognitions and depressive behaviors, 
the relation between depression and CR participation can be more fully understood. 
Methods: 56 patients at a local CR center were asked to complete a set of questionnaires 
assessing depressive symptoms, negative illness cognitions, and depressive behaviors as soon 
as possible during their CR program.  Then, their progress was tracked through CR and the 
number of sessions and completion status of the participants was recorded after they finished 
 
the program.   Relevant demographics were also analyzed to attempt to determine what may 
have the greatest impact on CR participation rates. 
Results: Results from this study suggested that there was not a significant association between 
depressive symptom clusters, negative illness cognitions, or depressive behaviors and the 
outcomes of number of sessions attended or CR completion status.  Participant age was a 
significant predictor of both outcomes, however, which indicated that younger CR patients 
attended fewer sessions and were less likely to complete the program than older patients.  In 
some analyses, education level was also a significant predictor of CR participation rates, with 
those having a college degree or higher attending more sessions than those without a college 
degree.  
Discussion: The current research found that there was not a significant association between 
specific symptoms of depression or related variables and CR participation.  Given that these 
results are not entirely consistent with previous literature in this area, it is possible that 
methodological limitations hindered the study’s ability to fully address the research question.  
However, the complicated findings in the literature and continued poor rates of participation in 
CR programs suggests that more research is needed in this area and the relation between 
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CHAPTER I: PROBLEM FORMULATION 
Cardiovascular diseases (CVDs) refer to various diseases which involve interrupted 
blood flow to the heart or heart rhythm irregularities and is one of the most prominent and lethal 
health problems in the world today.  According to the World Health Organization (WHO), CVDs 
are the number one cause of death globally, accounting for approximately 17.5 million deaths in 
2012 (31% of all global deaths) (WHO, 2015).  Considering how widespread this issue is, it is 
extremely important to continue researching means by which to improve the lives of those 
suffering from CVDs.  A key part of CVD care is cardiac rehabilitation (CR), which is a 
coordinated service involving several types of interventions to maximize a cardiac patient ’s 
overall functioning (Contractor, 2011).  Many of the risk factors for CVDs are behavioral in 
nature; poor diet, lack of physical activity, tobacco usage, and excessive alcohol consumption 
have all been linked to increased risk of CVD (WHO, 2015). Ultimately, CR attempts to reduce 
the risk factors associated with CVD, slow the progression of disease, and decrease overall and 
cardiac mortality through improved health behaviors (Heran et al., 2011).  These interventions 
include exercise, education about CVDs, psychological support, and overall health behavior 
change targeted at CVD risk factors, such as nutritional support (Heran et al., 2011). 
 There is a plethora of evidence for the effectiveness of CR at reducing overall mortality 
(Oldridge, Huyatt, Fischer, & Rimm, 1988; Goel, Lennon, Tilbury, Squires, & Thomas, 2011).  In 
a meta-analysis of over 4,300 patients, Oldridge and colleagues (1988) found that the odds 
ratios for all-cause death and cardiovascular death were both significantly lower among patients 
who attended CR.  A more recent review found similar results of decreased risk of overall and 
cardiac mortality amongst CR participants (Goel et al., 2011).  CR participation is also 
associated with greater aerobic capacity and a decrease in many CVD risk factors, such as total 
cholesterol levels, body weight, and smoking behavior (Contractor, 2011; Taylor et al., 2004; 




there is a strong dose-response relationship between number of CR sessions attended and 
long-term outcomes.  Although CR participation has not been shown to reduce all negative 
outcomes (Taylor et al., 2004; Goel et al., 2011), there is considerable evidence that CR is an 
extremely beneficial component of recovery from CVDs. 
 Despite the wealth of evidence that CR is effective at reducing mortality, many 
individuals referred to CR do not attend or do not complete the program (Arena et al., 2012).  
According to De Vos et al. (2013), international rates of attendance vary from 21% to 75%.  In 
an attempt to understand why more patients do not take advantage of CR, there have been 
myriad studies which have examined various factors which may contribute to patient non-
attendance.  Studies have examined physical barriers and disease severity (Clark et al., 2012; 
Grace et al., 2011; De Vos et al., 2013), demographic factors like age, gender, and ethnicity 
(Parashar et al., 2012; Valencia, Savage, & Ades, 2011; Buttery, Carr-White, Martin, Glaser, & 
Lowton, 2014), cognitive factors such as perceived control (Reges et al., 2013; Whitmarsh, 
Koutantji, & Sidell, 2003), social factors and social support (Meillier, Nielsen, Larsen, & Larsen, 
2012; King, Humen, Smith, Phan, & Teo, 2001), and psychological factors like depression and 
personality variables (Glazer, Emery, Frid, & Banyasz, 2002).  Despite the abundance of studies 
examining these factors, attendance and completion rates remain suboptimal, suggesting the 
need for additional research in determining more precise factors associated with CR non-
attendance, and thus identify intervention targets for increasing attendance.  
 One of the factors associated with CR non-attendance and CVDs in general which has 
received some attention in the literature is the impact of depression.  When examining the role 
of baseline depression on CR outcomes, however, some of the findings are mixed.  For 
example, one study determined that baseline depression accounted for 9.5% of the variance 
associated with increased aerobic capacity in a CR program (Glazer et al., 2002).  Another 




likelihood to complete the CR program (Casey, Hughes, Waechter, Josephson, & Rosneck, 
2008).  On the other hand, a study by Dickens, Cherrington, and McGowan (2011) found that 
the impact of depression on health-related quality of life (HRQoL) was mediated by other 
factors, including cardiac anxiety, awareness of somatic symptoms, and negative illness 
perceptions.  A similar study found that the negative association between depression and 
treatment adherence in a sample of heart failure patients was mediated by self-efficacy (Maeda, 
Shen, Schwarz, Farrell, & Mallon, 2013). 
Therefore, it is possible that other psychological variables closely related to depression 
may be important to evaluate when examining the relationship between depression and CR 
participation and outcomes.  Several researchers have attempted to accomplish this goal, 
examining other constructs which may be significantly related to or overlap with depression.  For 
example, Doyle, Conroy, and McGee (2007) performed a review which suggested several other 
constructs, including vital exhaustion, negative affective states and Type D personality, and 
negative illness cognitions could all be associated with depression-related mortality among 
patients with CVDs.  Other studies have also examined the relationship between depressive 
symptoms, cardiac outcomes, and associated factors such as fatigue (Pedersen et al., 2007), 
negative illness perceptions, and anxiety symptoms (Dickens, Cherrington, & McGowan, 2011).   
Additionally, a final aspect of depression which has received little attention in the 
literature is the influence of behaviors commonly associated with depression, such as avoidance 
behaviors, on CR attendance and completion.  Behavioral activation (BA) treatments view 
escape and avoidance behaviors as key components of maintaining depression, yet most 
common depression self-report questionnaires, such as the Beck Depression Inventory (BDI), 
do not specifically assess for these types of behaviors (Kanter, Mulick, Busch, Berlin, & Martell, 
2007).  Therefore, it may also be important to also study some of the behavioral components of 




completion.  While the presence of depression certainly appears to be important among patients 
with CVDs, there are plenty of other constructs and psychological factors which have been 
suggested to be better predictors of poor outcomes.  It is likely that depression plays some role 
in CR attendance and outcomes, but the complexity of findings in the literature suggests that 
this relation has yet to be entirely illuminated and more research is warranted. 
 One of the possible ways to further examine the association between depression and 
CR attendance and outcomes is to examine depressive symptoms individually, rather than 
depression as a whole.  Previous studies in general psychiatric samples, not CR patients, have 
demonstrated that depressive symptoms can be problematic, even without a full diagnosis of 
MDD.  For example, Lewinsohn, Solomon, Seeley, and Zeiss (2000) found that greater 
psychosocial distress, indicated by lower ratings of social interactions, life satisfaction, pleasant 
activities, and self-esteem, was associated with increasing levels of depressive symptoms.  
Other researchers have attempted to examine depressive symptom clusters, such as cognitive 
or somatic depressive symptoms.  A review by Vanheule, Desmet, Groenvynch, Rosseel, and 
Fontaine (2008) used a confirmatory factor analysis and found a three-factor model of the Beck 
Depression Inventory-II (BDI-II) involving cognitive, affective, and somatic symptoms to have the 
best fit.   
Using depressive symptom clusters has also yielded interesting findings in regards to 
depression and CVDs.  Several studies have found that patients with depression post-MI had 
significantly fewer cognitive symptoms than depressed outpatients without any CVDs (Martens 
et al., 2006; Groenewold et al., 2013).  Additionally, a recent meta-analysis suggested that 
somatic symptoms of depression, not cognitive or affective symptoms, are primarily responsible 
for poor CVD prognosis among patients with depression and CVD even after adjustment for 
disease severity (de Miranda Azevedo, Roest, Hoen, & de Jonge, 2014).  The relative 




patients with CVD has been suggested as one of the reasons why previous attempts to treat 
depression amongst this population, such as the Enhancing Recovery in Coronary Heart 
Disease (ENRICHD) study (Berkman et al., 2003), did not yield optimal results (Martens et al., 
2006).  However, it is important to note that some researchers have questioned the sole 
importance of somatic depressive symptoms (Carney & Freedland, 2012) and not all studies 
find that they are the only depressive symptoms that impact CVD prognosis (Frasure-Smith & 
Lesperance, 2003; Connerney, Sloan, Shapiro, Bagiella, & Seckman, 2010). 
 While much of the previous research has examined depressive symptom clusters and 
associated constructs among populations with CVD, only one study was found which examined 
the impact of specific depressive symptom clusters on CR attendance and outcomes.  In the 
study by Casey and colleagues (2008), exploratory analyses revealed that somatic symptoms of 
depression predicted dropout due to medical reasons better than cognitive-affective symptoms.  
However, the exploratory nature of the analyses used in that study and questions about the 
most accurate way to classify symptoms into symptom clusters both suggest the need for 
additional research in this area.     
It would be beneficial to be able to identify patients who may be at a greater risk of 
dropping out of CR and not reaping the benefits associated with participation, so examining 
more specifically what factors are associated with lack of participation is essential.  Therefore, 
there are several aims associated with the current study attempting to explore the association 
between depression and CR participation.  The first aim of this study is to examine the 
interrelationship between the psychosocial predictor variables: cognitive, affective, and somatic 
depressive symptom clusters; negative illness perceptions; and depressive behaviors.  The 
second aim and primary purpose of this study is to determine if particular depressive symptom 
clusters, as defined by the factor analysis conducted by Vanheule et al. (2008), affect the 




exploratory findings in the study by Casey and colleagues (2008), it is hypothesized that 
somatic symptoms of depression will have the most negative association with CR attendance 
and completion.  Additionally, due to the complex relationship between depression and the 
previously discussed associated constructs, the third aim of this study is to determine if other 
factors, such as negative illness cognitions or depressive behaviors, are better predictors of CR 










CHAPTER II: LITERATURE REVIEW 
Cardiovascular Disease  
Cardiovascular disease (CVD) is one of the most prominent and lethal health problems 
in the world today.  According to the World Health Organization (WHO), CVDs are the number 
one cause of death globally, accounting for approximately 17.5 million deaths in 2012 (31% of 
all global deaths) (WHO, 2015).  In the United States, it is estimated that approximately $444 
billion was spent on CVDs alone in 2010, with about $1 out of every $6 spent on health care 
being spent on the treatment of CVDs (CDC, 2010).  For the purposes of the current project, 
CVD is considered to be a group of discrete cardiovascular events or diagnoses that can result 
from either plaque buildup in the coronary arteries (coronary artery disease), which reduces the 
amount of oxygen and nutrients the heart receives, or electrical conduction and heart rhythm 
problems, which cause the heart muscle to beat irregularly.  Myocardial infarction (MI), stable 
and unstable angina, heart arrhythmias, and heart failure (HF) will be the primary focuses of this 
paper because of the prevalence of those conditions among patients in cardiovascular 
rehabilitation (CR) programs (Ades, 2001).  At the CR center where the current study will take 
place, the majority of patients eligible for referral to CR have coronary artery disease diagnoses, 
including acute MI, stable angina, and general coronary artery atherosclerosis.  Due to these 
diagnoses, many patients in CR have also recently undergone cardiac surgeries, such as 
coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI). 
Additionally, some of the patients eligible for CR referral have been diagnosed with heart failure, 
which represents a small but growing number of referrals to the present CR center.    
Coronary Artery Disease 
One of the main forms of CVD is coronary artery disease (CAD), which affects the blood 




Atherosclerosis occurs when plaque builds up on the walls of arteries, making blood flow more 
difficult (AHA, 2014c).  Atherosclerosis is driven by oxidative stress and increased inflammation 
of the arterial walls, which combine with the plaque buildup to decrease blood flow and make a 
complete blockage more likely (Scott, 2004). This entire process progresses slowly over time, 
usually over many years.  One of the most common risk factors for atherosclerosis is the level of 
circulating LDL cholesterol, which is often trapped in the arterial walls by oxidative processes 
(Scott, 2004).  Other traditional risk factors for atherosclerosis and general vascular obstruction 
include behavioral factors like smoking (Joosten et al., 2012) and physical inactivity (Laufs et al., 
2005).  More recent studies have begun to examine other risk factors for atherosclerosis, 
including insulin resistance related to obesity (Bornfeldt & Tabas, 2011) and general 
inflammatory processes (Hansson, 2005).  When atherosclerosis occurs and plaque builds up 
on the walls of the coronary arteries, blood flow to the heart is reduced, which limits the amount 
of oxygen and nutrients the heart receives.  If the heart muscle does not receive adequate 
oxygen, the cells of the heart can be damaged, which is known as ischemia (AHA, 2012). 
Myocardial Infarction 
Atherosclerosis can lead to a myocardial infarction (MI), commonly known as a heart 
attack, which occurs when blood flow to a portion of the heart is completely blocked.  The key 
pathology involved in a MI is heart cell death due to ischemia (Thygesen, Alpert, & White, 
2007).  Depending on the extent of the blockage and ischemia, a MI could be minor and 
undetected or it could be a major cardiovascular event which leads to sudden death or severe 
heart damage (Thygesen, Alpert, & White, 2007).  Regardless of the severity, the 
atherosclerotic process and blockage of the coronary arteries is a key cause of ischemia 
associated with MI.  To treat MI, patients may undergo a procedure known as thrombolysis, 
which involves injecting a clot-dissolving substance into the body to reduce the blockage and 




types of treatments for MI and other coronary artery diseases.  Two of the most common 
cardiac procedures are percutaneous coronary intervention (PCI), which involves inserting a 
catheter and stent to keep the coronary artery open for improved blood flow, and coronary 
artery bypass graft surgery (CABG), which involves using another blood vessel to circumvent 
the blockage and transport blood to the heart (AHA, 2014d). 
Angina 
Unstable angina is one of several forms of coronary artery disease which involves 
reduced blood flow to the heart muscle due to atherosclerosis in the coronary arteries 
(Anderson et al., 2013).  When plaque builds up in the coronary artery the plaque can rupture 
and injure the blood vessel, resulting in blood clotting and reduced blood flow to the heart 
(Anderson et al, 2013).  Once the rupture has occurred there is often unexpected chest pain, 
even at rest (AHA, 2013).  If the clotting associated with unstable angina is not addressed by a 
clinical intervention, a patient’s risk for subsequent MI and cardiac death is greatly increased 
(Anderson et al., 2013).  Once again, PCI and CABG are two of the main types of treatment for 
unstable angina to increase blood flow to the heart and reduce the amount of ischemic damage 
incurred by the heart (AHA, 2013).  Stable angina, similarly, is often caused by myocardial 
ischemic processes and atherosclerosis and results in pain in the chest, jaw, shoulder, back, or 
arms (Fox et al., 2006).  However, unlike unstable angina, the discomfort associated with stable 
angina is not due to ruptured plaque buildups but rather associated with reduced blood flow to 
the heart because of atherosclerosis (Fox et al., 2006).  Therefore, while unstable angina can 
result in random and unexpected chest pain, stable angina typically is more predictable and 
results in chest pain during periods of high cardiovascular exertion, such as during exercise or 






Aside from the coronary artery diseases, which all involve atherosclerosis and reduced 
blood flow to the heart, CVDs can also include conditions associated with abnormal electrical 
impulses within the heart.  An arrhythmia is any change from the normal pattern of electrical 
impulses within the heart (AHA, 2015a).  Arrhythmias can occur in many different forms, 
including the heart beating too rapidly (tachycardia), too slowly (bradycardia), and irregularly in 
either the atria or ventricles (examples include atrial and ventricular fibrillations) (AHA, 2015a).  
While some arrhythmias are often considered relatively benign, some types, such as ventricular 
fibrillations, are particularly dangerous because the heart begins to beat chaotically and can no 
longer pump blood efficiently to the body; cardiac arrest occurs when the heart’s electrical 
functioning begins to falter in this manner (AHA, 2014a).  If cardiac arrest occurs, the heart’s 
normal beating needs to be restored as soon as possible.  The most effective treatment to 
restore electrical functioning to the heart is a defibrillator, such as an automated external 
defibrillator (AED), which provides an electric shock to the heart in an attempt to restore normal 
rhythm (National Heart, Lung, and Blood Institute (NHLBI), 2011).  Cardiopulmonary 
resuscitation (CPR) is also recommended to attempt to maintain even minimal blood flow 
(NHLBI, 2011).  For people with arrhythmias or who may be at risk for future cardiac arrest, an 
implantable cardioverter defibrillator (ICD) may be implanted. In a meta-analysis of over 4,900 
patients at risk for sudden cardiac death or with other CVDs, ICDs were shown to be effective at 
preventing sudden cardiac death as both primary and secondary prevention techniques 
(Ezekowitz, Armstrong, & McAlister, 2003).  
While cardiac arrest and arrhythmias are not directly associated with a blockage of blood 
flow to the heart, ischemic and electrical processes can interact.  For example, an MI can cause 
cardiac arrest and sudden death because ischemic damage to the heart can result in 




MI, it is likely that the ischemic event led to a fatal arrhythmia, which then resulted in death 
(Thygesen, Alpert, & White, 2007).  Therefore, while coronary artery diseases such as unstable 
angina and MI are certainly major concerns, the disturbances in cardiac rhythm associated with 
arrhythmias are also essential to consider when examining CVDs.    
Heart Failure 
 Another type of CVD, often associated with both coronary artery issues and 
disturbances in cardiac rhythm, is heart failure (HF).  HF occurs when the heart cannot pump 
blood efficiently enough to meet the body’s oxygen and blood needs, and is often considered to 
be an end stage of CVD (AHA, 2015b).  Because the body is not receiving the optimal amount 
of oxygen and nutrients, the result is often fatigue and shortness of breath and everyday 
activities becoming difficult (AHA, 2015b).  When the heart loses the ability to pump blood 
efficiently, it often enlarges, develops more muscle mass, and pumps faster to compensate for 
the lack of power (AHA, 2015b).  Additionally, blood vessels throughout the body narrow to 
increase blood pressure to ensure blood reaches essential organs and provides them with 
sufficient nutrients (AHA, 2015b).  Some of the common risk factors for HF include high blood 
pressure, previous MI, heart valve damage, diabetes, sleep apnea, and others (AHA, 2015b).  
Some studies have suggested that coronary artery disease is the largest risk factor for 
developing HF, although it is often difficult to determine given the multitude of potential risk 
factors and causes (McMurray & Stewart, 2000).   
Cardiac Rehabilitation 
 A key part of heart disease care is cardiac rehabilitation (CR), which is a coordinated 
service involving several types of interventions to maximize a cardiac patient’s overall 
functioning (Contractor, 2011). According to the Centers for Medicare and Medicaid Services 




contractors (CMS, 2010b).  First, CR programs must include physician-prescribed exercise. 
Exercise frequency, intensity, and duration are prescribed for the individual client depending on 
their unique cardiovascular and medical status (Contractor, 2011).  CR often involves both 
aerobic exercises, in the form of walking, running, or cycling, and resistance exercises, such as 
hand weights, machines with low resistance, or elastic bands (Contractor, 2011).  Second, CR 
should include cardiac risk factor modification programs.  Many of the risk factors for CVDs are 
behavioral in nature; poor diet, lack of physical activity, tobacco usage, and excessive alcohol 
consumption have all been linked to increased risk of CVD (WHO, 2015). Therefore, CR 
attempts to reduce the risk factors associated with CVD and slow the progression of disease 
through improved health behaviors to decrease overall and cardiac mortality (Heran et al., 
2011).  For example, many CR programs involve management of common risk factors, such as 
lipid profiles, cholesterol, diabetes, and hypertension management, along with smoking 
cessation aid and weight loss strategies (Contractor, 2011). Third, CR programs are required to 
have psychosocial assessment, which should assess areas such as a patient’s family and home 
environment as it relates to their CR treatment and an evaluation of a patient’s response to 
treatment (CMS, 2010b).  The fourth required component in CR is objective outcomes 
assessment for each individual patient from commencement to conclusion of CR (CMS, 2010b).  
Finally, each patient is required to have a unique, written treatment plan based on a patient’s 
diagnosis, duration of the CR program, and goals (CMS, 2010b).  Overall, CR involves various 
interventions including exercise, education about CVDs, psychological support, and overall 
health behavior change targeted at CVD risk factors (Heran et al., 2011).   
CR can also occur in a variety of settings.  While many CR programs occur at medical 
centers, there have been studies which have examined the effectiveness of home-based CR 
programs containing the same types of interventions (Dalal, Zawada, Jolly, Moxham, & Taylor, 




involving clear objectives, patient monitoring, follow-up visits, letters and phone calls from staff, 
and some self-monitoring diaries (Dalal et al., 2010).  A large Cochrane systematic review found 
similar outcomes and benefits for cardiac patients among those who participated in center-
based and home-based CR programs (Dalal et al., 2010).  Therefore, CR appears to be 
effective at improving cardiac patients’ outcomes regardless of the setting. 
 While CR programs are tailored to individual patients based on their unique needs and 
initial cardiovascular fitness, the CMS provides general recommendations for program duration.  
Typically, up to 36 sessions are covered by Medicare, with a usual prescription of three 
sessions per week for 12 weeks (CMS, 2010a).  However, it is acceptable for a patient to 
complete the CR program early if the CR staff has determined that the patient has met their 
initial goals (CMS, 2010a).  For example, a patient may be identified as a candidate for early 
program termination if they have achieved a stable level of exercise tolerance without ischemia, 
have stable symptoms of angina or dyspnea at maximum exercise level, or have resting blood 
pressure and heart rate within normal limits (CMS, 2010a).  Additionally, patients with a 
cardiovascular stress test which is not indicative of additional problems are also eligible for early 
completion (CMS, 2010a).  On the other hand, coverage can be extended past 36 sessions on a 
case-by-case basis if sufficient evidence is provided that the exit criteria have not been met, but 
generally coverage will not exceed a maximum of 24 weeks (CMS, 2010a).   
Variability in the number of sessions required for an individual to complete CR has 
complicated the interpretation of studies examining CR outcomes, because defining what 
constitutes CR participation and completion has been difficult (Casey et al., 2008).  For 
example, a study by Lane, Carroll, Ring, Beevers, and Lip (2001) considered patients to have 
completed CR if they attended 50% or more of the prescribed sessions.  A study by Glazer and 
colleagues (2002) defined completion as attending 2/3 or more of the prescribed sessions.  




sessions or patients who achieved their prescribed goals and were permitted to discontinue the 
CR program early.  Due to the current CMS guidelines for CR program duration and the 
possibility for completion occurring before the prescribed number of sessions, utilizing CR goal 
achievement as a criterion for CR completion appears to be the most accurate way to define CR 
completion.  However, when considering the literature on CR attendance and completion, it is 
often complicated by these inconsistent definitions. At the Vidant Medical Center CR, 
participants who were considered to have completed the program participated in approximately 
26 sessions, on average. 
At the Vidant Medical Center CR where the current study took place, a patient is typically 
present for a single session of CR for around an hour to an hour and a half.  When they first 
arrive, patients are checked in and measurements are taken to establish safety before 
beginning exercise.  These measurements include weight, blood pressure, blood sugar for 
diabetic patients, heart rate, and oxygen saturation.  Then, patients warm up and participate in 
their individually prescribed exercise program.  Depending on the patient, the exercise segment 
of CR usually takes 20-45 minutes.  The educational components of CR take place in a 
multitude of settings and forms during the program, ranging from casual conversations between 
staff and patients during exercise to larger group education classes.  Patients normally meet 
three days per week until they have completed the program. 
 There is a plethora of evidence for the effectiveness of CR at reducing overall mortality 
(Oldridge et al., 1988; Goel et al., 2011).  In a meta-analysis of over 4,300 patients, Oldridge 
and colleagues (1988) found that the odds ratios for all-cause death and cardiovascular death 
were both significantly lower among patients who attended CR.  A larger meta-analysis by 
Taylor et al. (2004), which examined 8,940 patients with coronary heart disease, found reduced 
all-cause mortality and cardiac mortality compared to usual medical care.  These results were 




2004).  A more recent review used three different types of statistical analyses (propensity score-
matched analysis, propensity score stratification, and regression adjustment with propensity 
score in a 3-month landmark analysis) to examine the outcomes of nearly 2,400 patients who 
underwent PCI between 1994 and 2008 (Goel et al., 2011).  This study found similar results of 
decreased risk of overall and cardiac mortality amongst CR participants, and these results were 
the same regardless of gender or age (Goel, et al., 2011).   
CR participation is also associated with improved outcomes aside from mortality.  For 
example, exercise training, a key component of CR, has been associated with greater 
cardiovascular fitness and aerobic capacity (Fletcher et al., 1996).  According to the American 
Heart Association (AHA), exercise training can result in increased ventilatory oxygen uptake by 
increasing maximal cardiac output and decreasing the oxygen demands of the heart for the 
same level of external work (Fletcher et al., 1996).  Additionally, in the meta-analysis by Taylor 
et al. (2004), CR was associated with larger decreases in cholesterol levels, triglyceride levels, 
systolic blood pressure, and even smoking behavior.  These findings would be supported by the 
AHA, which suggests that exercise training in general improves lipid metabolism and body 
weight (Fletcher et al., 1996).  CR has even been shown to be effective at reducing depression 
following treatment (Milani & Lavie, 2007). 
To obtain all of the benefits of CR, however, it appears to be important to attend as 
many sessions as possible.  Hammill and colleagues (2010) suggest there is a strong dose-
response relationship between number of CR sessions attended and long-term outcomes.  In an 
analysis of over 30,000 patients who attended at least one outpatient CR session at a 
healthcare facility, those who attended 36 sessions had a 47% lower risk of death than those 
who attended only 1 session (Hammill et al., 2010).  Additionally, those who attended 36 
sessions had a 14% lower risk of death than those who attended 24 sessions, even after 




hospitalizations (Hammill et al., 2010).  Therefore, while there are numerous studies which have 
demonstrated the efficacy of CR on a diverse array of outcomes, it may require patients to 
attend as many sessions as possible to reap the full benefits.  
CR participation has not been shown to reduce all negative outcomes, however.  For 
example, some of the aforementioned reviews did not find an association between CR 
participation and nonfatal MI or revascularization (Oldridge et al., 1988; Goel et al., 2011).  The 
meta-analysis by Taylor et al. (2004) found no significant differences in rates of nonfatal MI or 
revascularization as well, along with no significant differences in HDL or LDL cholesterol levels 
and diastolic blood pressure among patients in CR compared to those in usual medical care.  
Taylor et al. (2004) also found that health-related quality of life improved among both groups, 
although there was no significant effect of CR participation.  Therefore, while CR appears to 
have many positive effects on the recovery of people with CVDs, regardless of gender or age 
(Menezes, Lavie, DeSchutter, & Milani, 2014), it has not been shown to reduce all negative 
consequences of CVDs. 
 Despite the wealth of evidence that CR is effective at reducing mortality, many 
individuals referred to CR do not attend or do not complete the program (Arena et al., 2012).  
According to De Vos et al. (2013), international rates of attendance vary from 21% to 75%.  In a 
study of 526 discharged CR patients in the United States, the rate of completion of a CR 
program was only 58%, with 63% of those who did not complete the program dropping out due 
to non-medical reasons such as transportation issues, financial difficulties, or a personal 
decision not to continue the program (Sanderson, Phillips, Gerald, DiLillo, & Bittner, 2003).  The 
other 37% of the patients who dropped out in this sample did not complete the program due to a 
medical condition or complication (Sanderson et al., 2003).  In an older population of 226 
patients aged 62 or older who were diagnosed with acute MI or underwent CABG, Ades, 




eligible Medicare patients who experienced an MI or underwent a CABG procedure, only 14% to 
31% took part in a CR program following these cardiac events (Suaya et al., 2007). Overall, the 
rates of attendance and completion of CR programs are lower than would be expected 
considering the immense amount of benefits which have been associated with participation in 
CR.   
Barriers to CR- Disease Severity/Physical Barriers 
In an attempt to understand why more patients do not take advantage of CR, there have 
been myriad studies which have examined various factors which may contribute to patient non-
attendance.  Some studies have examined physical barriers and disease severity as possible 
reasons for sub-optimal CR participation rates.  Most studies have found that factors other than 
disease severity are more important for CR participation; Ades and colleagues (1992) suggest 
that medical factors such as cardiac diagnosis and left ventricular ejection fraction (LVEF) did 
not predict CR participation in a study of 226 older patients.  Additionally, Clark et al. (2012) 
found that patients’ stated reasons for attending CR were likely to involve a wide range of 
factors, but medical reasons like symptom severity and comorbidities were not typically 
discussed.  However, some studies have demonstrated various cardiac diagnoses and risk 
factors are correlated with poorer CR participation.  In a review of 18 studies published between 
1990 and 2009, Taylor, Wilson, and Sharp (2011) found four studies that reported significant 
effects of cardiac diagnosis on CR adherence, along with three studies which showed 
decreased adherence among active smokers and two studies which suggested patients with a 
higher body mass index (BMI) had worse CR adherence.  Some other physical factors which 
have been consistently associated with decreased CR participation include distance to the CR 
center, lack of time, cost of the program, lack of transportation, and poor referral strategies (De 
Vos et al., 2013; Grace et al., 2011; Jackson, Leclerc, Erskine, & Linden, 2005).  Additionally, 




referred to CR and non-participation in CR programs (Jackson et al., 2005; Sun, Jadotte, & 
Halperin, 2016). 
Barriers to CR- Demographics 
Demographic factors like age, gender, and ethnicity have also been studied in relation to 
CR attendance and completion. Some studies suggest that there are significant differences in 
CR participation among different demographic groups.  For example, Fletcher et al. (1996) 
suggests that there may be sex biases in referral rates to CR and attendance rates, with women 
being referred less and having higher dropout rates and compliance problems.  Menezes and 
colleagues (2014) reviewed the literature and found women and minorities received fewer 
referrals to CR programs despite the potential to receive similar benefits to men and 
Caucasians.  In a study of almost 2,100 patients with acute MI, Parashar et al. (2012) found 
similar results for women, discovering that women were less likely to participate in CR at one 
month post-hospital discharge.  Parashar et al. (2012) also found that older patients and 
minority patients were less likely to participate in CR at 6 months post-hospital discharge.  
Valencia, Savage, and Ades (2011) reviewed literature on CR participation among minority 
patients and patients with low SES and found that both of those factors resulted in lower rates of 
participation.  A study of 106 older patients with heart failure, aged 65 years or older, 
demonstrated that only 21% of this elderly population was even referred to CR, indicating 
another possible group which is not obtaining the benefits of CR at an acceptable rate (Buttery 
et al., 2014). Another recent meta-analysis of 21 studies found that odds of CR participation 
were lower in older individuals, females, those with a high school degree or less, and those 
without current employment (Sun et al., 2016).  Not all studies have found these demographic 
differences, however.  A study of over 4,400 patients enrolled in CR did not find any significant 
gender differences in program adherence, although minorities were significantly less likely to 




CR attendance and completion rates are typically low overall, it appears that specific 
demographic groups, like minorities or women, may be at an even greater risk of not attending 
CR or not completing the program.   
Barriers to CR- Psychosocial Barriers 
Furthermore, aside from physical barriers and demographic differences, some 
researchers have examined the effect of various psychosocial variables on CR participation.  
One of the constructs which has been studied in relation to CR attendance is illness cognition 
and perception of disease.  Reges et al. (2013) studied 420 hospitalized patients with acute MI 
or acute coronary syndrome (ACS) and found cognitions about the benefits of exercise and 
perceived control over the disease were both significantly associated with participation in CR.  
Similarly, a study by Whitmarsh, Koutantji, and Sidell (2003) found that lower perception of 
symptom number and severity and less controllability and curability of disease was associated 
with decreased CR attendance.  They also looked at the effect of coping strategies on CR 
attendance and found that the use of problem-focused and emotion-focused coping were 
correlated with increased CR participation (Whitmarsh et al., 2003).  The use of maladaptive 
coping strategies, such as denial, mental disengagement, and behavioral disengagement, was 
alternatively associated with poorer CR participation (Whitmarsh et al., 2003).   
Some studies have also examined various social factors in an attempt to understand the 
low levels of CR attendance and completion.  King, Humen, Smith, Phan, and Teo (2001) 
examined the effects of a diverse group of psychosocial variables in a sample of over 300 
patients with acute MI or CABG surgery.  This study found that women and older participants 
reported less perceived social support, but there was no significant association between social 
support and CR attendance (King et al., 2001).  These results are in contrast to other findings in 




Craigs, Hill, Honey, and House (2012), suggested that support from family and friends was one 
of the factors which most consistently was associated with increased uptake of lifestyle change 
programs.  Additionally, King and colleagues (2001) found that patients who demonstrated 
higher levels of role resumption at two weeks post-MI were less likely to participate in CR.  
These researchers posit that patients who attempt to resume normal roles soon after MI may 
inherently not believe they are in need of rehabilitation, leading to less CR participation.  In one 
attempt to address social differences, Meillier and colleagues (2012) assigned socially 
vulnerable patients to an enhanced CR program with the goal of increasing CR attendance.  
The enhanced CR program involved extra nurse-led consultation, additional time to design and 
implement idiographic plans for CR, skills-training elements, and extra activities at local 
community centers.  Socially vulnerable patients were described as individuals with low 
education, living alone, or experiencing high life stress and a lack of social support.  By 
assigning the socially vulnerable patients to the enhanced CR program, this study achieved an 
attendance rate of 93% for all patients referred to CR (Meillier et al., 2012).  The lack of 
randomization and absence of a control group are significant limitations to that study, but the 
results are promising for the importance of taking into account psychosocial factors when 
attempting to remedy the problem of sub-optimal CR participation, especially considering the 
vulnerability for mental health issues conferred by high stress and lack of social support.  
Some studies have even examined the role of personality characteristics, such as 
optimism and neuroticism, on CR attendance and outcomes, but have not found significant 
effects (Glazer et al., 2002).  Overall, researchers have discovered both primary access issues, 
such as insurance coverage, transportation problems, and distance to CR center (Jackson et 
al., 2005), and secondary access issues, such as psychological and social variables (Whitmarsh 
et al., 2003), which are associated with CR non-attendance and non-completion.  While both 




secondary access issues may interact.  For example, depending on a patient’s perception of 
their illness, the distance to the CR center may be more or less of an important factor in 
determining attendance.  Additionally, studies have demonstrated that some secondary access 
issues, such as depression, can significantly reduce compliance to medical regimens (DiMatteo, 
Lepper, & Croghan, 2000).  Even if transportation is available, the avoidance behaviors and 
avolition associated with depression may inhibit individuals from taking advantage of the 
opportunities that they do have.  Large reviews examining referral and adherence predictors 
appear to support the heterogeneity of these factors; for example, a large review of over 16,800 
eligible patients demonstrated that a wide variety of factors, encompassing both primary and 
secondary access issues, were independent predictors for CR referral and adherence (Jackson 
et al., 2005).  Therefore, studying secondary access issues like psychosocial predictors of CR 
attendance and completion should still be viewed as a worthwhile and necessary part of this 
literature. Despite the abundance of studies examining a multitude of demographic, physical, 
and psychosocial factors, CR attendance and completion rates remain suboptimal, suggesting 
the need for additional research in determining more precise factors associated with CR non-
attendance. 
Depression and Cardiovascular Disease 
 One of the factors associated with CR non-attendance and CVDs in general which has 
received some attention is depression.  Major Depressive Disorder (MDD), as defined by the 
DSM-5, occurs when five or more of the following symptoms have been present for at least the 
same two-week period: depressed mood, anhedonia, weight loss or gain, insomnia or 
hypersomnia, psychomotor agitation or retardation, fatigue, feelings of worthlessness or guilt, 
lack of concentration, and recurrent thoughts of death or suicidal ideation (American Psychiatric 




anhedonia, the symptoms must cause clinically significant distress, and the depressive episode 
cannot be caused by any substances or other medical conditions (APA, 2013).  
When examining the role of baseline depression on CR attendance and outcomes, many 
studies have found a negative association.  For example, one study determined that baseline 
depressive symptoms, as measured by the BDI, accounted for 9.5% of the variance associated 
with increased aerobic capacity in a CR program (Glazer et al., 2002).  The researchers 
measured aerobic capacity as maximum oxygen consumption and controlled for relevant 
demographic variables and attendance rates, but the sample only included 46 patients in a 12-
week CR program (Glazer et al., 2002).  Another study examining 600 patients in CR for a wide 
array of CVDs found that depression was negatively associated with likelihood to complete the 
CR program (Casey et al., 2008).  In this study, a logistic regression demonstrated that patients 
with elevated depression scores (scores of more than 10 on the Beck Depression Inventory) 
were 2.2 times less likely to complete CR than patients with lower depression scores, even after 
controlling for age and gender (Casey et al., 2008).  Additional analyses suggested that only 
age also predicted completion, with older patients being more likely to complete CR; gender, 
BMI, and employment status all failed to significantly predict CR completion (Casey et al., 
2008).  A study by Swardfager and colleagues (2011) supported these findings, showing that 
CR patients who met DSM-IV criteria for MDD were less likely to complete CR, attended fewer 
sessions, achieved worse aerobic fitness increases, and reduced body fat to a lesser extent 
than patients who did not meet criteria for MDD.  According to these studies, depression is a 
significant predictor of poor CR participation and outcomes. 
On the other hand, not all studies have demonstrated that depression is a unique 
predictor of negative outcomes for patients with CVDs, with some research suggesting that 
other psychological variables related to depression may better account for the negative 




depressive symptoms, as measured by the Hospital Anxiety and Depression Scale (HADS), 
were associated with lower health-related quality of life (HRQoL) in a sample of 255 primary 
care patients with coronary heart disease; however, the impact of depression on HRQoL was 
mediated by other psychological factors, including cardiac anxiety, awareness of somatic 
symptoms, and negative illness perceptions.  Another study found that self-efficacy mediated 
the relationship between depressive symptoms, as measured by the Center for Epidemiological 
Studies - Depression Scale (CES-D), and treatment adherence in a sample of 252 HF patients, 
further suggesting that other psychological factors may be intertwined in the association 
between depression and cardiovascular outcomes (Maeda et al., 2013).   
Therefore, it is possible that other psychological variables closely related to depression 
may be important to evaluate when examining the relation between depression and CR 
participation and outcomes.  Several researchers have attempted to accomplish this goal, 
examining other constructs which may be significantly related to or overlap with depression.  For 
example, Doyle, Conroy, and McGee (2007) performed a review which suggested several other 
factors, including vital exhaustion, negative affective states and Type D personality, and 
negative illness cognitions could all be associated with depression-related mortality among 
patients with CVDs.  According to this review, vital exhaustion is defined as feelings of excess 
fatigue, energy loss, irritability, and demoralization; it has been associated with poor 
cardiovascular outcomes and depression, although there are significant overlaps in the 
constructs (Doyle et al., 2007).  Pedersen and colleagues (2007) also examined this association 
in a study of 534 patients who underwent PCI.  At 2-year follow-up, vital exhaustion was 
associated with poor cardiac outcomes, although after adjustment it was no longer significant 
(Pedersen et al., 2007).  Type D personality, which consists of the combination of negative 
affectivity and social inhibition, has also been associated with depression and increased 




to depression and CVDs is distorted illness cognitions.  In their review, Doyle et al. (2007) 
suggest that some studies have observed relations between illness perception and depression 
in CHD patients but larger studies often have contradictory results about the influence of 
negative illness cognitions on depression and health behaviors.  Another review, specifically 
focused on the impact of illness perceptions on CR attendance, found that a few specific illness 
cognitions significantly predicted CR participation; however, the results from their meta-analysis 
were often mixed and had small effect sizes (French, Cooper, & Weinman, 2006). While the 
presence of depression certainly appears to be important among patients with CVDs, there are 
numerous other constructs and psychological factors which have been suggested to also be 
predictors of poor outcomes.  Depression is likely to play some role in CR attendance and 
outcomes, but the complexity of findings in the literature suggests that this relation has yet to be 
entirely illuminated and more research is warranted. 
A final aspect of depression which has received little attention in the literature is the 
influence of behaviors commonly associated with depression, such as avoidance behaviors, on 
CR attendance and completion.  Behavioral activation (BA) treatments view escape and 
avoidance behaviors as key components of maintaining depression, yet most common 
depression self-report questionnaires, such as the BDI, do not specifically assess for these 
types of behaviors (Kanter et al., 2007).  Therefore, Kanter and colleagues (2007) created the 
Behavioral Activation for Depression Scale (BADS) in order to more specifically assess for 
escape and avoidance behaviors related to depression.  In the BADS, some examples of 
avoidance behaviors include “I stayed in bed too long even though I had things to do” and “I was 
not social, even though I had opportunities to be”.  Some studies have suggested that 
avoidance may be associated with non-attendance at CR (Farley, Wade, & Birchmore, 2003), 




be important to also study some of the behavioral components of depression when attempting 
to understand the effect of depression on CR attendance and completion. 
 One of the possible ways to further examine the association between depression and 
CR attendance and outcomes is to examine depressive symptoms, rather than depression as a 
whole.  Previous studies of psychiatric patients without CVDs have demonstrated that 
depressive symptoms can be problematic even without a full diagnosis of MDD.  For example, 
Lewinsohn and colleagues (2000) found that psychosocial distress increased with increasing 
levels of depressive symptoms.  In this study, psychosocial distress included measures of social 
support, social interactions, life satisfaction, pleasant activities, and self-esteem, among others; 
when depressive symptoms were elevated, patients were more likely to report lower life 
satisfaction, fewer pleasant activities, lower self-esteem, and other indicators of psychosocial 
distress.  Increased levels of psychosocial distress were observed in patients even with sub-
threshold levels of depressive symptoms, indicating that even a few depressive symptoms could 
be troublesome.  According to the researchers, these results support the fact that depressive 
symptoms can be clinically significant even when a diagnosis of MDD has not been met 
(Lewinsohn et al., 2000).   
Other researchers have attempted to examine depressive symptom clusters, such as 
depressive cognitions or somatic symptoms, in addition to individual depressive symptoms.  
Determining how to differentiate which symptoms are included in which clusters has been 
problematic, however, and different researchers have used varying models to assess 
depressive symptom clusters throughout the literature.  Some researchers have pointed out this 
discrepancy and called into question many findings which have examined the impact of specific 
depressive symptom clusters, validly claiming that some symptoms are viewed within one 
cluster in some studies and within a different cluster in other studies (Carney & Freedland, 




needed.  A review by Vanheule and colleagues (2008) attempted to accomplish this goal by 
looking at ten different models of the Beck Depression Inventory-II (BDI-II) and utilizing 
confirmatory factor analysis to determine which model of depressive symptom clusters 
demonstrated the best fit.  While none of the models which looked at all 21 BDI-II items 
demonstrated a good fit, several shortened models with items deleted displayed a good fit and 
were posited as sufficient ways to examine depressive symptom clusters.  A two-factor model 
with a cognitive factor and a somatic-affective factor and a three-factor model involving 
cognitive, affective, and somatic factors had the best fit, but the researchers preferred the three-
factor model because it more clearly differentiates between somatic and affective symptoms 
(Vanheule et al., 2008).  According to this factor structure, symptoms such as pessimism and 
worthlessness would be considered cognitive symptoms of depression.  Loss of pleasure, 
crying, and loss of interest are included as affective symptoms of depression.  Finally, change in 
sleeping pattern, concentration difficulties, and changes in appetite are examples of somatic 
symptoms of depression.  Therefore, although the literature is mixed with regards to how to best 
define the clusters of symptoms associated with depression, the three-factor model tested by 
Vanheule and colleagues (2008) appears to be the most accurate, evidence-based model to 
date. 
Using depressive symptom clusters has also yielded interesting findings in regards to 
depression and CVD.  Several studies have found that patients with depression post-MI had 
significantly fewer cognitive symptoms than depressed outpatients without any CVDs (Martens 
et al., 2006; Groenewold et al., 2013).  Martens and colleagues (2006) conducted a study which 
examined 40 depressed patients post-MI, 40 patients without depression post-MI, and 40 
psychiatric outpatients with depression to determine if depression was similar in cardiac and 
non-cardiac populations.  Mean levels of depressive cognitions, as measured by the Beck 




sample than the cardiac sample with depression (Martens et al., 2006).  In addition to those 
findings, Martens et al. (2006) found that psychiatric patients with depression had higher levels 
of overall depressive symptoms than post-MI patients with depression, indicating that 
depression between these two populations may be both qualitatively and quantitatively different.  
Groenewold et al. (2013) performed a similar study with a larger sample, including 194 patients 
post-MI, 214 patients in primary care settings, and 326 mental health care patients.  Patients 
post-MI and in primary care settings reported significantly lower cognitive/affective symptoms 
than patients in mental health care settings, even after controlling for recurrence of depression 
(Groenewold et al., 2013).  However, these results were not as strong as Martens and 
colleagues (2006) found, because the differences disappeared after controlling for age of onset.  
There were no differences among reported somatic symptoms between the three groups either 
(Groenewold et al., 2013).  Therefore, while there may be other factors involved, depression in 
cardiac populations may be different than depression seen in mental health care settings.   
Additionally, a recent meta-analysis suggested that somatic/affective symptoms of 
depression, not cognitive/affective symptoms, are primarily responsible for poor CVD prognosis 
among patients with depression and CVD (de Miranda Azevedo et al., 2014).  In this review, 13 
studies were included with a total of 11,128 subjects who presented with a wide range of CVDs 
and whose depression was measured using reliable and valid measures.  The breakdown of 
depressive symptoms into cognitive/affective and somatic/affective was completed by 
examining the 13 included studies and the individual symptom clusters in those studies; while 
there was some disagreement amongst the studies included, the agreement on symptom 
assignment to the two categories was moderate (κ =0.60) (de Miranda Azevedo et al., 2014).  In 
analyses that included adjustment for disease severity, somatic/affective symptoms, but not 
cognitive/affective symptoms, were associated with worse cardiovascular outcomes, such as 




Miranda Azevedo et al., 2014).  Specifically, a one standard deviation increase in 
somatic/affective symptoms was associated with a 32% increased risk in negative outcomes (de 
Miranda Azevedo et al., 2014).  According to this meta-analysis, specific depressive symptoms 
may be more problematic for patients with CVDs and depression and supports the idea of 
studying depressive symptom clusters rather than depression as a whole amongst this 
population. 
The relative importance of somatic symptoms and lack of importance of cognitive 
symptoms in depressed patients with CVD has been suggested as one of the reasons why 
previous attempts to treat depression amongst patients with CVDs, such as the Enhancing 
Recovery in Coronary Heart Disease (ENRICHD) study (Berkman et al., 2003), did not yield 
optimal results (Martens et al., 2006).  The main finding of the ENRICHD trial was that 
psychosocial intervention for post-MI patients successfully reduced depressive symptoms but 
did not lead to decreased mortality rates (Berkman et al., 2003).  It has been suggested that the 
mode of treatment in the ENRICHD trial, cognitive-behavioral therapy focused on cognitive 
restructuring, may not have been ideal because of the differences in cognitive and somatic 
symptoms in patients with depression and CVD (Martens et al., 2006).  If somatic symptoms are 
primarily important for cardiovascular prognosis (de Miranda Azevedo et al., 2014) and there 
are fewer cognitive symptoms of depression in cardiac populations (Martens et al., 2006), a 
cognitive approach to treating depression in individuals with depression and CVD may not be 
effective in reducing CVD mortality.  This idea is partially supported by secondary analyses of 
the ENRICHD study as well.  In an analysis of 1,254 patients from the ENRICHD study by Roest 
et al. (2013), decreases in somatic depressive symptoms among the intervention group (treated 
with CBT) were associated with reduced risk of recurrent MI and mortality, even after adjusting 
for baseline depression and demographic and clinical variables.  On the other hand, decreases 




(Roest et al., 2013).  Ultimately, while depression treatment overall did not improve 
cardiovascular outcomes in the ENRICHD trial, it appears that decreases in somatic depressive 
symptoms specifically did have a significant effect on improving outcomes.   
It is important to note that some researchers have questioned the sole importance of 
somatic depressive symptoms in cardiac populations (Carney & Freedland, 2012).  Carney and 
Freedland (2012) reviewed the literature on depression within this population and acknowledged 
the complexity of findings in this area.  While some studies have found somatic symptoms to be 
predictors of worse cardiovascular outcomes, the differences in methodologies and ways of 
defining the depressive symptom clusters has complicated the interpretation of the findings 
(Carney & Freedland, 2012).  Additionally, the researchers point out criticisms which question 
whether somatic symptoms of depression are uniquely associated with depression or 
confounded with CVD symptoms (Carney & Freedland, 2012).  However, many studies, 
including the meta-analysis by de Miranda Azevedo and colleagues (2014), statistically control 
for disease severity using standard indices for CVD severity and risk factors. The use of well-
validated measures is another method which can aid in avoiding confounding somatic 
symptoms of depression with CVD symptoms.  For example, Thombs and colleagues (2010) 
found that the BDI-II did not appear to inflate somatic symptoms of depression in a sample of 
post-MI patients with depression.   
Another piece of evidence against somatic symptoms being primarily responsible for 
poor outcomes is that not all studies have found this association (Frasure-Smith & Lespérance, 
2003; Connerney et al., 2010).  For example, Frasure-Smith and Lespérance (2003) found that 
lower overall depression scores on the BDI and both cognitive and somatic subscales were 
associated with decreased cardiac-related mortality at five years post-MI.  This study was 
performed on nearly 900 patients post-MI, and the results retained significance even after 




Connerney and colleagues (2010) provides even more counter-evidence; in a prospective study 
of 309 patients who underwent CABG surgery, the researchers found that overall depressive 
symptoms and cognitive/affective symptoms, measured by the BDI, were predictors of cardiac 
mortality.  The somatic symptom subscale was not significantly associated with either all-cause 
mortality or cardiac mortality (Connerney et al., 2010).  Considering the wealth of evidence for 
the importance of somatic depressive symptoms in cardiac patients, it is likely that these 
symptoms play a significant role in a patient’s recovery and well-being.  On the other hand, the 
conflicting findings within the literature suggest that there is a need for more research in this 
area to clarify the relation between depressive symptom clusters and cardiac outcomes. 
Aims and Hypotheses of the Current Study 
 While much of the previous research has examined depressive symptom clusters and 
associated constructs among populations with CVD, only one study was found which examined 
the impact of specific depressive symptom clusters on CR attendance and outcomes.  In the 
study by Casey and colleagues (2008), exploratory analyses revealed that somatic symptoms of 
depression predicted dropout due to medical reasons better than cognitive-affective symptoms.  
However, this study used the first 13 items of the BDI-I as cognitive-affective symptoms and the 
last 8 items as somatic symptoms, which may not be an ideal way to examine the various 
symptom clusters (Carney & Freedland, 2012).  Additionally, because the results were 
exploratory analyses, the researchers suggest future research is necessary to further elucidate 
the finding (Casey et al., 2008).   
 Furthermore, it may also be important to study psychological constructs related to 
depression in addition to examining depressive symptom clusters.  As noted previously, other 
factors related to depression have also been associated with poor CR outcomes (Doyle et al., 




additional variables.  Illness cognitions were chosen because of the lack of evidence in the 
literature surrounding the importance of cognitive symptoms of depression among populations 
with depression and cardiovascular disease.  It is possible that traditional measures of 
depression, such as the Beck Depression Inventory (BDI), may not assess depressive 
cognitions as well in this population because their cognitions are primarily illness-related 
cognitions, rather than general depressive cognitions.  If that is true, it could help explain why 
negative illness perceptions appear to be related to negative cardiovascular outcomes, while 
this association is not consistently found for cognitive symptoms of depression.   
Depressive behaviors are also of interest because traditional measures of depression, 
such as the BDI, do not specifically assess behaviors which may be maintaining depression.  
The lack of existing measures to assess depressive behaviors prompted the development of the 
Behavioral Activation for Depression Scale (BADS) (Kanter et al., 2007).  It is possible that 
behaviors which maintain depression, such as avoidance behaviors, are also significantly 
detrimental to individuals attending and completing CR programs.  Therefore, for the purposes 
of the current study, illness cognitions and depressive behaviors will also be measured along 
with depressive symptom clusters.  
It would be beneficial to be able to identify patients who may be at a greater risk of 
dropping out of CR and not reaping the benefits associated with participation, so examining 
more specifically what factors are associated with lack of participation is essential.  Therefore, 
there will be several aims associated with the current study attempting to explore the 
association between depression and CR participation.  The first aim of this study is to examine 
the interrelationship between the psychosocial predictor variables, such as cognitive, affective, 
and somatic depressive symptom clusters, negative illness perceptions, and depressive 
behaviors to determine the uniqueness of these measures and facilitate interpretation of the 




correlated, but that correlation coefficients will be small (e.g. < .3) indicating that they are 
primarily unique constructs. Based on observed correlation coefficients as described in Aim 1, 
the second aim and primary purpose of this study is to determine if particular depressive 
symptom clusters, as defined by the factor analysis conducted by Vanheule and colleagues 
(2008), predict the attendance and completion rates of patients participating in a CR program.  
Based on the exploratory findings in the study by Casey and colleagues (2008), we hypothesize 
that somatic symptoms of depression will have the strongest negative association with CR 
attendance and completion.  Additionally, due to the complex relationship between depression 
and the previously discussed associated constructs, the third aim of this study is to explore if 
other factors, such as negative illness cognitions or depressive behaviors, are better predictors 
of CR attendance or outcomes than clusters of depressive symptoms. 
 
 
CHAPTER III: METHODS 
Participants 
Participants were recruited from the Vidant Medical Center Cardiovascular Pulmonary 
Rehabilitation (CVPR) program.  The sample for this study included 56 participants (41.1% 
female, 35.7% African-American) with an age range of 32-84 years old.  Participants with any 
cardiovascular diagnosis given as the primary reason for referral were invited to participate.  
Participants in this study were referred to CR for a wide array of CVD conditions, including PCI 
or CABG procedures, MI events, angina, and HF.  Participants in CVPR with a pulmonary 
diagnosis as the primary reason for attendance were not be recruited for this study; however, 
participants were not excluded for any other reasons as long as they could read and speak 
English to consent to the study.  According to power analysis, a sample of approximately 55 
would be required to achieve acceptable power based on a medium effect size to test the 
effects of depressive symptom clusters on CR attendance and completion (second aim).  
Therefore, the minimum goal for participant recruitment was achieved (See Appendix B).   
Measures 
Beck Depression Inventory- II (BDI-II) (Beck, Steer, & Brown, 1996): The BDI-II is a widely 
used 21-item self-report questionnaire used to measure depressive symptoms.  The BDI-II asks 
participants to rate the severity of depressive symptoms during the past two week period.  It 
differs from the BDI-I in that four items were deleted (Weight Loss, Body Image Change, 
Somatic Preoccupation, and Work Difficulty) and replaced by four new items (Agitation, 
Worthlessness, Concentration Difficulty, and Loss of Energy) (Beck et al., 1996).  Additionally, 
questions about appetite and sleep change were changed to allow for both increases and 
decreases, and many questions were slightly reworded (Beck et al., 1996).  It has been 




somatic symptom inflation in the BDI from symptom overlap between depression and MI (Delisle 
et al., 2012).  In one study, 296 patients post-MI and 296 psychiatric outpatients were examined 
using the BDI and matched on cognitive-affective BDI scores, sex, and age; the researchers 
found that the post-MI patients endorsed significantly more somatic symptoms than the 
psychiatric patients (Delisle et al., 2012).  In a similar study using the BDI-II, somatic symptom 
scores were not significantly higher in a post-MI sample than a psychiatric sample (Thombs et 
al., 2010). 
Behavioral Activation for Depression Scale (BADS) (Kanter et al., 2007): The BADS is a 25-
item self-report questionnaire used to measure avoidance behaviors that lead to a lack of 
environmental reinforcement and thus maintenance of depressive symptoms (see Appendix C).  
The BADS contains four subscales, including Activation, Avoidance/Rumination, Work/School 
Impairment, and Social Impairment.  It asks participants to determine how true each of the 25 
statements was during the past week on a seven-point scale, ranging from 0 (not at all) to 6 
(completely).  Some of the items are reverse-coded.  Overall, the BADS has been shown to 
have good internal consistency (Cronbach’s α = .87; Cronbach’s α for each subscale range from 
.76 to .86) and acceptable test-retest reliability (r = 0.74) (Kanter et al., 2007). 
Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent, Petrie, Main, & Weinman, 
2006): The Brief IPQ is a 9-item self-report questionnaire used to measure cognitive and 
emotional representations of illness (see Appendix D).  The Brief IPQ is based on the Illness 
Perception Questionnaire-Revised (IPQ-R), which is an 80-item self-report questionnaire (Moss-
Morris et al., 2002).  The Brief IPQ was developed by creating one question that summarized 
each subscale of the IPQ-R and adding an open-ended question to determine causal 
representations (Broadbent et al., 2006).  Tests of the psychometric properties of the Brief IPQ 
have demonstrated that it is a valid and reliable measure of illness perceptions among a diverse 




used the Brief IPQ suggested that this measure is predictive of a variety of outcomes among a 
diverse range of illnesses (Broadbent et al., 2015).  
Procedure 
This study occurred in the Vidant Medical Center Cardiovascular Pulmonary 
Rehabilitation center.  Potential participants were approached by a trained member of the 
nursing staff as early as possible during their standard CR program.  While patients were ideally 
approached during their first session when they were filling out other paperwork, time 
constraints with the normal clinic flow did not allow this to always occur; results indicated that 
participants were approached on average 10 days after program enrollment.  When approached 
by one of the CVPR nurses, patients were informed about the current study and asked if they 
would be interested in participating.  If interested, participants read and signed the informed 
consent document and then were given three measures to fill out, including the BDI-II, BADS, 
and Brief IPQ.  Additionally, participants filled out a demographics form, including their age, 
town in which they live, and time that it requires them to reach the CR center.  Upon completion 
of filling out the forms, participants were provided with a small $5 gift card as compensation for 
participation. The paper questionnaires did not have identifying information on them, but were 
stored with the patient’s informed consent form in order to match participant questionnaire data 
with their CR data.  These folders were stored in a locked file cabinet in the CVPR center to 
protect confidentiality, and informed consent forms were removed after collected data were 
associated with CR data.   
After filling out baseline forms, participants were tracked as they progressed through the 
CR program as part of standard care.  Once a participant was no longer attending the program, 
the patient’s record was reviewed and entered into the American Association of Cardiovascular 




PI) as part of standard practice.  The AACVPR reporting site includes some demographic and 
identifying information and outcomes throughout the CR program.  Additionally, these data 
include the number of sessions a patient completed, number of sessions prescribed, and 
whether they were considered to have completed the CR program.  A patient was considered to 
have completed the program if deemed to have met treatment goals by a member of the CVPR 
staff.  After termination of CR, several pieces of data were utilized from the AACVPR reporting 
site database.  The number of sessions attended by each participant and whether they are 
considered to have completed the program by CR staff was recorded, along with distance 
walked during the six-minute walk test.  Additionally, covariates which were used for analyses 
can also be found in this dataset.  Data from the three questionnaires were then matched to the 
participants’ CR outcome data.  After matching participants’ CR data to their psychosocial 
questionnaire responses, any unnecessary identifying information, such as names, zip codes, 
and dates of birth, were deleted to protect confidentiality.    
Analysis 
All data analysis was conducted using IBM SPSS Statistics 24 and α was set at 0.05 for 
all analyses.  For the initial aim of determining the interrelationship between the predictor 
variables, a correlation table was utilized and Pearson correlation coefficients were examined.  
For the second aim, which involved examining the effect of depressive symptom clusters on CR 
participation, two regressions were used.  First, a linear regression with cognitive, affective, and 
somatic clusters as predictor variables in the same model was conducted to determine if 
depressive symptom clusters predict number of CR sessions attended.  Then, a binary logistic 
regression was utilized with the same three predictor variables in one model to examine if the 
depressive symptom clusters predict CR program completion.  For the third aim, regression 
analyses were also conducted to examine the effect of the three depressive symptom clusters, 




regressions were conducted with the BDI-II subscales, Brief IPQ, and BADS subscales in 
separate models to determine if they predict number of CR sessions attended.  Then, three 
binary logistic regressions were conducted with the same predictor variables to examine if they 
predict completion of the CR program.  Demographic characteristics such as age, gender, 
education level, and race were analyzed as potential covariates in adjusted analyses.  
Additionally, AACVPR risk stratification was examined as a potential covariate to adjust for 
possible influences of disease severity or the type of diagnosis.  These covariates can all be 
found in the data which were downloaded from the AACVPR reporting site.  All analyses were 
completed with crude and adjusted models; crude models were unadjusted, while adjusted 













CHAPTER IV: RESULTS 
Demographics of the Sample 
The sample for this study consisted of 56 participants.  Overall, the sample contained 23 
women (41.1%) and 33 men (58.9%), with an age range of 32-84 years old (M=60.00, 
SD=12.00).  The sample was predominantly Caucasian (57.1%; n=32), with 20 (35.7%) African-
American participants (4 participants did not report race).  Education level was dichotomized 
into those who had less than a college degree and those with a college degree or above.  
Twenty-two participants (39.2%) reported an educational level below that of a college graduate, 
while 13 participants (23.2%) endorsed being a college graduate or having post-graduate 
education; twenty-one participants (37.5%) did not report an education level, however.  Half of 
the sample was classified as high risk by the CVPR staff (n=28).  Overall, 43 participants 
(76.8%) completed the CR program and 13 participants (23.2%) did not complete.  
Demographic information is presented in Table 1, which contrasts demographic information 












Table 1: Demographics of Completers and Non-Completers and of the Overall Sample. 
Demographics Completers (N=43) Non-Completers (N=13) Total Sample (N=56) 
Gender    
Male 27 (62.8%) 6 (46.2%) 33 (58.9%) 
Female 16 (37.2%) 7 (53.8%) 23 (41.1%) 
Race    
Caucasian 25 (58.1%)  7 (53.8%) 32 (57.1%) 
African-American 15 (34.9%) 5 (38.5%) 20 (35.7%) 
Age    
Mean Age 63.36 ± 10.36 50.08 ± 11.62 60.00 ± 12.00 
Education Level    
Below College 
Graduate 
13 (30.2%) 9 (69.2%)  22 (39.2%) 
College Graduate or 
Above 
12 (27.9%) 1 (7.7%) 13 (22.8%) 
AACVPR Risk 
Category 
   
Low Risk 10 (23.3%) 2 (15.4%) 12 (21.1%) 
Intermediate Risk 5 (11.6%) 1 (7.7%) 6 (10.5%) 
High Risk 20 (46.5%) 8 (61.5%) 28 (49.1%) 
 
 First, analyses were conducted to determine which demographics were significantly 
related to the outcomes of number of sessions attended, program completion status, and 
increase in walk distance from intake to discharge. A correlation table was created for 
continuous demographics (age) and t-tests were utilized to examine the association between 
categorical demographics (gender, race, education level, and risk category) and the continuous 
outcomes of number of sessions attended and increase in walk distance.  For the dichotomous 




square analyses were utilized for categorical demographics (gender, race, education level, and 
risk category).  The results of these analyses are presented in Table 2 below.  Briefly, older age 
(r=.429, p=.001) and higher level of education (t=-2.509, p=.017) were significantly correlated 
with number of sessions attended, and older age (t=-3.925, p< .001) and higher level of 
education (χ2=4.42, p= .036) were also significantly associated with completion status.  There 
were no demographics which were significantly associated with increases in walk distance, so 
no subsequent adjusted model was analyzed for this outcome.   
Table 2: Association between Demographics and Outcomes 




Association with Increase in 
walk distance 
Gender t=1.858 Χ2=1.142 t=.933 
Race t=.575 Χ2=0.068 t=-.239 
Education 
Level 
t=-2.509* Χ2=4.418* t=-.711 
AACVPR Risk 
Category 
F=2.069 Χ2=0.853 F=1.904 
Age r=.429** t=-3.925** r=-.149 
*Significant at the p<.05 level  **Significant at the p<.01 level 
Hypothesis #1: Interrelationship of the Predictors 
To determine the interrelationship between the predictor variables in the study, a 
correlation table was created and Pearson correlation coefficients were examined.  The 
correlation table for the main predictor variables (BDI-II subscales, Brief IPQ, and BADS 




Figure 1: Correlations for Interrelationship of Predictors 
 
Many of the predictor variables were significantly correlated with other predictors in the 
sample.  The BDI-II subscales were significantly correlated to one another, the Brief IPQ total 
score, and all BADS subscales except for the Activation subscale.  The Brief IPQ total score 
was also significantly correlated with all BADS subscales except for the Activation subscale.   
Hypothesis #2a: BDI-II Subscales and Number of Sessions Attended 
 For the second hypothesis, a linear regression was utilized to examine the effect of the 
BDI-II depressive symptom clusters on number of CR sessions attended, controlling for known 
covariates.  First, a crude linear regression was utilized with only the BDI-II subscales in the 
same model.  The results can be seen in Table 3.  Briefly, none of the BDI-II subscales were 
statistically significant predictors of number of CR sessions attended.  Then, an adjusted model 




and education level were included in the same linear regression model, and the results are 
shown in Table 3. Even in the adjusted model, the BDI-II subscales were not predictive of more 
sessions attended.  Participant age, on the other hand, was significantly associated with number 
of sessions attended (t=2.277, p=.031), with older participants being more likely to engage in 
more sessions.  Additionally, there was a trend towards significance with education level 
(t=1.884, p=.070), suggesting participants with a college degree or higher were somewhat more 
likely to attend a greater number of CR sessions.  
Table 3: Linear Regression Results for #Sessions Attended 
Predictors Unstandardized 
Beta Weight (B) 
Test Statistic (t) Significance 
BDI-II Subscales 
Alone 
   
BDI-II Cognitive -0.14 -0.160 p=.874 
BDI-II Affective 0.21 0.216 p=.830 
BDI-II Somatic -0.31 -0.752 p=.455 
BDI-II Subscales + 
Age and Education 
Level 
   
BDI-II Cognitive 0.25 0.191 p=.850 
BDI-Affective -0.63 -0.440 p=.664 
BDI-II Somatic -0.07 -0.134 p=.894 
Age 0.26 2.277 p=.031* 
Education Level 5.67 1.884 p=.070 






Hypothesis #2b: BDI-II Subscales and Completion Status 
To examine the relation between BDI-II subscales and participant completion status for 
the CR program, a binary logistic regression was utilized.  First, a crude binary logistic 
regression was utilized with only the BDI-II subscales in the same model.  The results can be 
seen in Table 4.  As with number of sessions completed, none of the BDI-II subscales alone 
were statistically significant predictors of completion status.  Then, an adjusted model was 
created utilizing the significant demographics (see Table 2).  The BDI-II subscales and age and 
education level were included in the same binary logistic regression model, and the results are 
shown in Table 4.  As with the unadjusted model, the BDI-II subscale scores were not significant 
predictors of completion in the adjusted model either.  While the subscale scores were not 
predictive of completion, age was a significant predictor for completion status (Wald χ2=4.199, 
p=.040), even with education level and BDI-II subscale scores in the same model.  These 
results suggest that participants who completed CR were significantly older than those who did 












Table 4: Binary Logistic Regression Results for Completion Status 







   
BDI-II Cognitive -0.06 0.046 p=.830 
BDI-II Affective 0.13 0.187 p=.666 
BDI-II Somatic -0.14 1.356 p=.244 
BDI-II Subscales + 
Age and Education 
Level 
   
BDI-II Cognitive -0.23 0.306 p=.580 
BDI-Affective 0.41 0.613 p=.434 
BDI-II Somatic -0.16 0.543 p=.461 
Age 0.10 4.199 p=.040* 
Education Level 2.08 2.240 p=.134 
*Significant at the p<.05 level  
Hypothesis #3a: All Predictors and Number of Sessions Attended 
For the third hypothesis, linear regressions were utilized to examine the effect of the 
BDI-II depressive symptom clusters, Brief IPQ total score, and BADS subscales on number of 
CR sessions attended.  First, crude linear regressions were utilized with only the predictors, and 
the results can be seen in Table 5.  Briefly, none of the predictors were significant predictors of 
number of CR sessions attended.  Then, the same adjusted model from the linear regression for 
hypothesis #2 was utilized using the significant demographics (see Table 2).  The predictors 
were analyzed with age and education level included, and the results are shown in Table 5.  
Once again, none of the psychosocial predictors were significant predictors in the adjusted 




predictors in nearly all models, except education level became non-significant in the model 
controlling for BDI-II subscale scores.  Even after controlling for Brief IPQ total score and BADS 
subscales, older participants and those with a college degree or higher were more likely to 
attend more sessions than younger and less educated participants.  




Test Statistic (t)  Significance  
BDI-II Subscales Alone    
BDI-II Cognitive -0.14 -0.160 p=.874 
BDI-II Affective 0.21 0.216 p=.830 
BDI-II Somatic -0.31 -0.752 p=.455 
BDI-II Subscales + Age 
and Education Level 
   
BDI-II Cognitive 0.25 0.191 p=.850 
BDI-Affective -0.63 -0.440 p=.664 
BDI-II Somatic -0.07 -0.134 p=.894 
Age 0.26 2.277 p=.031* 
Education Level 5.67 1.884 p=.070 
Brief IPQ Total Alone    
Brief IPQ Total -0.02 -0.219 p=.827 
Brief IPQ Total + Age and 
Education Level 
   
Brief IPQ Total 0.09 0.744 p=.462 
Age 0.28 2.748 p=.010* 
Education Level 6.91 2.405 p=.023* 




BADS Activation 0.01 0.072 p=.943 
BADS 
Avoidance/Rumination 
0.11 0.833 p=.409 
BADS Work/School 0.06 0.198 p=.844 
BADS Social -0.13 -0.492 p=.625 
BADS Subscales + Age 
and Education Level 
   
BADS Activation -0.01 -0.075 p=.941 
BADS 
Avoidance/Rumination 
-0.15 -0.688 p=.498 
BADS Work/School 0.08 0.235 p=.816 
BADS Social 0.06 0.134 p=.894 
Age 0.28 2.455 p=.021* 
Education Level 8.70 2.321 p=.029* 
*Significant at the p<.05 level 
Hypothesis #3b: All Predictors and Completion Status 
To examine the association between BDI-II subscales, Brief IPQ total score, and BADS 
subscales and participant completion status for the CR program, binary logistic regressions 
were utilized.  First, crude binary logistic regressions were used with only the psychosocial 
predictors.  The results can be seen in Table 6.  As with previous analyses, none of the 
predictors were significantly associated with CR completion status.  Then, adjusted models 
were created utilizing the significant demographics (see Table 2).  The predictors and age and 
education level were included in binary logistic regression analyses, and the results are shown 
in Table 6.  As with the previous analyses, psychosocial predictors were non-significant but 
participant age was a significant predictor of CR completion status when controlling for all 




younger participants in this sample.  Education level was marginally associated with completion 
status when controlling for the Brief IPQ total score, but was not significant after controlling for 
BDI-II subscale or BADS subscale scores. 
Table 6: Binary Logistic Regression Results for Completion Status 
Predictors Unstandardized 




BDI-II Subscales Alone    
BDI-II Cognitive -0.06 0.046 p=.830 
BDI-II Affective 0.13 0.187 p=.666 
BDI-II Somatic -0.14 1.356 p=.244 
BDI-II Subscales + Age 
and Education Level 
   
BDI-II Cognitive -0.23 0.306 p=.580 
BDI-Affective 0.41 0.613 p=.434 
BDI-II Somatic -0.16 0.543 p=.461 
Age 0.10 4.199 p=.040* 
Education Level 2.08 2.240 p=.134 
Brief IPQ Total Alone    
Brief IPQ Total -0.02 0.292 p=.985 
Brief IPQ Total + Age and 
Education Level 
   
Brief IPQ Total 0.02 0.100 p=.752 
Age 0.11 5.680 p=.017* 
Education Level 2.31 3.058 p=.080 
BADS Subscales Alone    
BADS Activation -0.02 0.157 p=.692 





BADS Work/School 0.08 0.859 p=.354 
BADS Social -0.10 1.269 p=.260 
BADS Subscales + Age 
and Education Level 
   
BADS Activation -0.04 0.355 p=.551 
BADS 
Avoidance/Rumination 
0.02 0.058 p=.809 
BADS Work/School 0.01 0.011 p=.917 
BADS Social -0.04 0.045 p=.833 
Age 0.10 3.899 p=.048* 
Education Level 1.91 1.602 p=.206 
*Significant at the p<.05 level 
Post-Hoc Exploratory Analyses 
 Following the main analyses, post-hoc analyses were conducted to explore whether 
individual BDI-II or BADS subscales were significant predictors of CR attendance or completion 
status. These analyses were also non-significant, however, suggesting that none of the 
psychosocial predictors were significant predictors of CR participation even when analyzed in 






CHAPTER V: DISCUSSION 
Review of the Results 
 The current study sought to examine the role of depressive symptom clusters and 
related psychosocial variables on attendance and completion in a cardiac rehabilitation 
program.  Overall, however, the hypotheses were not supported by the data.  For the first 
hypothesis, the psychosocial predictor variables (BDI-II cognitive, affective, and somatic 
symptoms, Brief IPQ total score, and BADS subscales) were more correlated than hypothesized 
(see Figure 1).  For example, the BDI-II cognitive subscale had a Pearson correlation coefficient 
of 0.457 with the Brief IPQ total score, indicating that there was significant overlap in these 
measures.  Therefore, while the goal was to measure illness-specific cognitions as a separate 
construct from general depressive cognitions, that may not have been achieved in this study.  It 
is not as surprising that the subscales of the BDI-II and BADS were significantly correlated, as 
the BADS was shown to have convergent validity with the BDI-II during its development (Kanter 
et al., 2007); however, it is difficult to draw distinct conclusions from each measure given that 
the data suggest they were more correlated than originally hypothesized.   
 For the main hypothesis of this study, none of the depressive symptom clusters were 
shown to be predictors of either number of sessions attended or completion status.  It was 
hypothesized that somatic symptoms of depression may be stronger predictors of CR 
participation given that previous literature has suggested more adverse outcomes for CVD 
patients with increased somatic symptoms of depression compared to cognitive symptoms (de 
Miranda Azevedo et al., 2014).  Additionally, the null results from this study do not corroborate 
the exploratory findings from Casey and colleagues (2008), which found that somatic symptoms 
of depression, but not cognitive-affective symptoms, predicted CR participation rates.  As 




depressive symptom clusters, rather than simply splitting the BDI measure, resulted in a better 
view of cognitive, affective, and somatic symptoms of depression and resulted in different 
findings.  Additionally, this study utilized the BDI-II instead of the original BDI, which has been 
shown to have less somatic symptom inflation in post-MI patients (Delisle et al., 2012; Thombs 
et al., 2010); this could have also contributed to the discrepant findings from Casey and 
colleagues (2008). 
 For the exploratory hypothesis of including the Brief IPQ and BADS as predictors, the 
results did not support the idea that these measures would be better predictors of CR 
participation than depressive symptoms.  Neither the crude nor adjusted analyses showed that 
any of the psychosocial predictors were associated with CR sessions attended or completion 
status.  Once again, this result is surprising given that previous studies have shown that a 
construct like illness perception is often associated with CR attendance (French, Cooper, & 
Weinman, 2006).  While there is not much previous literature on using measures of depressive 
behaviors as predictors of CR participation, it was hypothesized that individuals who were more 
behaviorally inactivated, as measured by the BADS, may be less likely to engage in a program 
like CR.  However, the results did not seem to support this hypothesis.  Given that CR has been 
shown to be effective at reducing depression (Milani & Lavie, 2007), it is possible that 
participants who were slightly depressed and behaviorally inactivated at the beginning of the 
program began to feel better from engaging in a program like CR, which reinforced them 
attending sessions.   
While the psychosocial predictors were not associated with number of sessions attended 
or completion status, several demographic factors were significant predictors even while 
examining depressive symptoms, depressive behaviors, and negative illness cognitions in the 
same model.  Primarily, participant age was a significant predictor of both number of sessions 




CR program than older individuals.  This finding also appears to be contrary to previous results 
from the literature, which often suggest that older individuals have lower rates of participation in 
CR (Parashar et al., 2012; Sun et al., 2016).  It is not entirely clear why younger participants 
would have been less likely to complete the CR program; however, given that this study 
included a wide range of participant ages, with participants as young as 32 years old, it is 
possible that younger patients still were employed and had to work, therefore being unable to 
attend as many sessions or complete the program.  Additionally, previous studies have 
suggested that younger individuals with CVD, like heart failure, may encounter particular 
difficulties because of how age-discordant their disease seems (Tippey, 2014).  Therefore, 
young individuals may be less inclined to participate in CR because of discomfort or stigma 
attached to having CVD at such a young age and primarily being surrounded by older patients 
at a CR center.  It is also conceivable that younger patients attending fewer sessions of CR is 
not indicative of a lack of participation, but the possibility that younger CR patients are able to 
meet their prescribed CR goals in fewer sessions than older patients.  Given that program 
completion may occur when the CR staff deems a patient has met their CR goals, it is therefore 
possible that younger individuals are more aerobically fit and require fewer sessions attended to 
complete the program. On the other hand, younger age was still significant associated with 
being less likely to complete CR, so this explanation obviously would not explain all of the 
results from this study.  While a higher level of education was significantly associated with 
increased number of sessions attended, this association was not found in analyses including 
BDI-II subscale scores.  Interestingly, gender and race were not significantly associated with 
either number of sessions completed or completion status; while some studies have suggested 
that these demographics are often predictors of CR non-participation (Parashar et al., 2012), the 





Limitations of the Current Research 
 As noted above, some of the results of this study appear to be contrasted to results 
typically found within the literature in this area.  Therefore, it is possible that some of the 
limitations of the methodology of the current study may be affecting the results.  In the final 
sample, nearly 77% of the participants in the study completed the CR program, which is a 
significantly higher completion rate than previous research has found (Sanderson et al., 2003). 
Therefore, it is possible that the sample was not representative of the population of CR patients.  
There are several possible explanations for why the sample in this study may not generalize to 
other studies.  While the ultimate goal was to attempt to obtain baseline psychosocial measures 
on a patient’s first session at CR, it became apparent that the patients were often too busy with 
normal clinic procedures during that first session to be informed about the study and fill out 
more questionnaires.  Therefore, although the average time between CR initiation and filling out 
the questionnaires was 10 days, there were likely some CR patients who only showed up for the 
first session or two and stopped returning before they were approached to participate in this 
study.  Given that previous research has suggested that most patients who drop out of a CR 
program will do so early, often in the first two weeks (Casey et al., 2008; Yohannes, Yalfani, 
Doherty, & Bundy, 2007), it is possible that the inability to obtain measures from patients during 
their first session lowers the generalizability of these findings.  Similarly, some patients declined 
to participate when approached with information about the study; although data were not 
collected on the number of patients who declined to participate, it is possible that those who 
voluntarily participated in this study were less depressed or more amenable to the CR program, 
and therefore less likely to drop out.   
 In addition to the aforementioned limitations, there were several other potential 
limitations to the current study which should be considered when interpreting the results.  First, 




the necessary sample size was obtained for adequate power, it is possible that some of the 
results which were approaching significance would have been observable with a larger sample.  
Additionally, the current study seemed to have underrepresented the prevalence of non-
completers.  As noted previously, another possible limitation is that the psychosocial measures 
were highly correlated; therefore, it is also possible that the unique constructs which we 
attempted to measure were not adequately measured.  This study also utilized self-report 
measures of depression, depressive behaviors, and illness cognitions, which could have 
resulted in participants trying to respond favorably to appear as if they were coping with their 
illness well.  Similarly, some of the items on the measures, particularly the Brief IPQ, may not 
have adequately measured negative cognitions within this population.  For example, an illness 
cognition elicited by the Brief IPQ asks about perceived time the disease will continue; for some 
patients in this sample, their perceptions of their disease state lasting for the rest of their life 
may be accurate, not a negative illness cognition.  Overall, the limitations to this study should be 
carefully considered when examining the results. 
Strengths and Future Directions 
 The current study exhibited several notable strengths.  For example, the depressive 
symptom clusters were defined using evidence from the literature, rather than simply splitting up 
the BDI-II conceptually (Vanheule et al., 2008; Carney & Freedland, 2012).  Similarly, based on 
the difficulty within the literature in defining CR participation, two different measures of 
participation (number of sessions attended and completion status) were utilized to try and obtain 
an accurate view of patient participation.  Additionally, this is the only study we could find which 
examined depressive symptom clusters, depressive behaviors, and illness cognitions in the 
same study, to try and provide a complete view of the role of depression in CR attendance and 




patients of a wide age range and approximately 35% of the sample endorsing an African-
American race.   
 There are numerous directions which future research in this area should explore.  Given 
that these results contrast with some of the results in other areas of the literature, more 
research is needed to further understand the role depression plays in CR attendance and 
completion.  Other methods of determining depression to supplement self-report measures, like 
structured interviews, may provide additional information about the role of depressive symptoms 
on CR participation.  Future studies could also seek to replicate a study like this with a larger 
sample and a procedure which allows potential participants to be approached earlier in 
treatment, to try and examine a more representative population.   
Final Conclusions 
 Overall, the results from this study do not support the idea that specific depressive 
symptom clusters are associated with a lack of CR participation.  None of the psychosocial 
predictors, including depressive symptom clusters, negative illness perceptions, or depressive 
behaviors were significantly related to number of CR sessions attended or completion status.  In 
fact, the only consistently significant predictor of CR participation was participant age, with older 
individuals being more likely to complete CR and attend more sessions.  These results should 
be interpreted cautiously, given that they appear to contrast with several different studies and 
that the current study had some considerable limitations.  Taken altogether, however, it is still 
likely that psychosocial variables like depression are somehow associated with some of the 
difficulties noted with CR participation; more studies in this area are needed, however, in order 
to fully elucidate this association and be better able to design interventions to improve 
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APPENDIX C: Informed Consent Document 
East Carolina University 
 
 
Informed Consent to Participate in Research 
Information to consider before taking part in research that has no 
more than minimal risk. 
 
Title of Research Study: The Influence of Cognitive, Affective, and Somatic Symptoms of 
Depression and Related Psychosocial Variables on Cardiovascular Rehabilitation Participation 
  
Principal Investigator: John Taylor Freeman (Person in Charge of this Study) 
Faculty Supervisor: Matthew C. Whited, Ph.D., Associate Professor of Psychology at East 
Carolina University 
Institution, Department or Division: East Carolina University Psychology Department 
Address: 237 RAWL Building, East Carolina University, Greenville, NC 27858 
Telephone #: 252-328-1069 
 
Participant Full Name:  __________________________Date of Birth:  ___________________                                            
Please PRINT clearly 
 
 
Researchers at East Carolina University (ECU) and Vidant Medical Center Cardiovascular 
Pulmonary Rehabilitation (CVPR) study issues related to society, health problems, 
environmental problems, behavior problems and the human condition.  To do this, we need the 
help of volunteers who are willing to take part in research. 
 
Why am I being invited to take part in this research? 
The purpose of this research is to examine some psychological factors which may be 
associated with why people decide to stop participating in a cardiac rehabilitation program.  You 
are being invited to take part in this research because you are eligible to participate in cardiac 
rehabilitation. The decision to take part in this research is yours to make.  By doing this 
research, we hope to learn why people may decide to stop participating in cardiac rehabilitation 
programs and possibly design ways to increase attendance rates in cardiac rehabilitation in the 
future.  
 
If you volunteer to take part in this research, you will be one of about 55 people to do so.   
 
Are there reasons I should not take part in this research?  
You should not volunteer for this research if you are participating in the Vidant CVPR program 
for a pulmonary diagnosis, instead of a cardiac diagnosis.  Additionally, if you cannot speak 
English, you should not take part in this research. 
 
What other choices do I have if I do not take part in this research? 
You can freely choose not to participate, and it will not affect your cardiac rehabilitation program 
at all.  If you choose not to participate, you will receive the same cardiac rehabilitation program 







Where is the research going to take place and how long will it last? 
The research will be conducted at the Vidant Cardiovascular and Pulmonary Rehabilitation 
(CVPR) center. You will need to come to the Vidant CVPR center one time for the purposes of 
this study.  The total amount of time you will be asked to volunteer for this study is 
approximately 20-30 minutes during the first day of your regularly prescribed CVPR program.   
 
 
What will I be asked to do? 
You will be asked to do the following: during your first session of CVPR, you will be given three 
questionnaires to read and fill out.  The first questionnaire is the Beck Depression Inventory-II, 
which is a 21-item survey that measures common depressive symptoms any person may be 
experiencing.  The second questionnaire is the Behavioral Activation for Depression Scale, 
which is a 25-item survey that measures behaviors a person may engage in which are often 
associated with depression.  The third questionnaire is the Brief Illness Perception 
Questionnaire, which is a 9-item survey that assesses a person’s thoughts and attitudes about 
their illness.  You will be asked to fill out all three surveys during your first session of CVPR, and 
that will be the only thing you will be asked to do.  After you have filled out the questionnaires, 
you will participate in cardiac rehabilitation as normal.  When you are finished with cardiac 
rehabilitation, we (the researchers) will examine your chart and match up your questionnaire 
answers with data collected during your cardiac rehabilitation program. 
 
What might I experience if I take part in the research? 
We don’t know of any risks (the chance of harm) associated with this research.  Any risks that 
may occur with this research are no more than what you would experience in everyday life.  We 
don't know if you will benefit from taking part in this study.  There may not be any personal 
benefit to you but the information gained by doing this research may help others in the future. 
 
Will I be paid for taking part in this research? 
You will be provided with a $5 gift card for participating in this research.   
  
Will it cost me to take part in this research?  
It will not cost you any money to be part of the research. 
 
Who will know that I took part in this research and learn personal information 
about me? 
ECU and the people and organizations listed below may know that you took part in this research 
and may see information about you that is normally kept private.  With your permission, these 
people may use your private information to do this research: 
 Any agency of the federal, state, or local government that regulates human research.  This 
includes the Department of Health and Human Services (DHHS), the North Carolina 
Department of Health, and the Office for Human Research Protections. 
 The University & Medical Center Institutional Review Board (UMCIRB) and its staff have 
responsibility for overseeing your welfare during this research and may need to see 
research records that identify you.  
 People designated by Vidant Medical Center and Vidant Health 
 If you are a patient at ECU or Vidant, a copy of the first page of this form will be placed in 
your medical records.   





We will share only the PHI listed above with the individuals/agencies listed above.  If we need to 
share other PHI or if we need to send PHI to other individuals/agencies not listed above, we will 
ask for your permission in writing again 
 
What type of Protected Health Information (PHI) will be collected? 
When taking part in research, protected health information (PHI) is collected, used, and shared 
with others who are involved in the research.  Federal laws require that researchers and health 
care providers protect your PHI. Also, federal laws require that we get your permission to use 
collected PHI for the research. This permission is called authorization.  
 
In order to complete the research project in which you have decided to take part, the research 
team needs to collect and use some of your PHI as described below. 
 
 Medical/clinic records from Vidant Cardiovascular and Pulmonary Rehabilitation (CVPR) 
 Records generated during this study 
 
How my PHI may be released to others: 
ECU and Vidant Medical Center (VMC) are required under law to protect your PHI.  However, 
those individuals or agencies who receive your PHI may not be required by the Federal privacy 
laws to protect it and may share your PHI with others without your permission, if permitted by 
the laws governing them.  
 
What if I do not sign this form? 
You will not be eligible to participate in this study if you do not sign this Authorization form. 
 
How may I revoke (take back) my authorization? 
You have the right to stop sharing your PHI.   To revoke (or take back) your authorization, you 
must give the Principal Investigator your request to revoke (or take back) your authorization in 
writing. If you request that we stop collecting your PHI for the study, you may be removed from 
the study.  If you are removed from the study, it will not affect your ability to receive standard 
medical care or affect payment, health plan enrollment or benefit eligibility.   PHI collected for 
the research study prior to revoking (or taking back) your Authorization will continue to be used 
for the purposes of the research study.   
 
Restrictions on access to my PHI: 
You will not be able to see your PHI in your medical record related to this study until the study is 
complete.  If it is necessary for your care, your PHI will be provided to you or your physician. 
 
How long may the PHI about me be used or disclosed for this study? 
Research information continues to be looked at after the study is finished so it is difficult to say 
when use of your PHI will stop.  There is not an expiration date for this authorization to use and 
disclose your PHI for this study. 
 
If you have questions about the sharing of PHI related to this research study, call the principal 
investigator John Taylor Freeman at phone number 252-328-1069. Also, you may telephone the 
University and Medical Center Institutional Review Board at 252-744-2914.  In addition, if you 
have concerns about confidentiality and privacy rights, you may phone the Privacy Officer at 






How will you keep the information you collect about me secure?  How long will 
you keep it? 
The paper surveys you fill out will be stored in a locked file cabinet in a locked room at the 
Vidant CVPR site to protect confidentiality.  These paper forms will include some of your PHI, 
including your hometown and age, but all forms will be stored securely in a locked file cabinet in 
a locked room at Vidant CVPR.  When we access your cardiac rehabilitation data, we will use 
the secure American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) 
reporting site used by CVPR staff to protect confidentiality.  This electronic data will be stored 
on the secure ECU Psychology department Pirate Drive, which is a password protected file only 
accessible by authorized individuals.  Additionally, when the data is reviewed, unnecessary 
identifiers, such as your name, date of birth, zip code, and medical record ID, will be deleted.  
Your age will remain in the electronic data, which is considered PHI if you are older than 89 
years old.  Therefore, the electronic data may contain some of your PHI, but it will be stored 
securely on the ECU Psychology department Pirate Drive.  The data we collect may be used for 
presentations and educational opportunities, but all data will be presented based on all 
participants’ scores, and your data will still be anonymous. 
 
What if I decide I don’t want to continue in this research? 
You can stop at any time after it has already started. There will be no consequences if you stop 
and you will not be criticized.  You will not lose any benefits that you normally receive.  
 
Who should I contact if I have questions? 
The people conducting this study will be able to answer any questions concerning this research, 
now or in the future.  You may contact the Principal Investigator at 252-328-1069 (Monday to 
Friday, 9:00AM to 5:00PM). 
    
If you have questions about your rights as someone taking part in research, you may call the 
Office of Research Integrity & Compliance (ORIC) at phone number 252-328-9473 (Monday to 
Friday, 8:00 am-5:00 pm).  If you would like to report a complaint or concern about this research 
study, you may call the Director of the ORIC, at 252-744-1971 and the Vidant Medical Center 
Risk Management Office at 252-847-5246 
 
I have decided I want to take part in this research.  What should I do now? 
The person obtaining informed consent will ask you to read the following and if you agree, you 
should sign this form:   
 
 I have read (or had read to me) all of the above information.   
 I have had an opportunity to ask questions about things in this research I did not 
understand and have received satisfactory answers.   
 I know that I can stop taking part in this study at any time.   
 By signing this informed consent form, I am not giving up any of my rights.   
 I have been given a copy of this consent document, and it is mine to keep.  
 
 
          _____________ 






Person Obtaining Informed Consent:  I have conducted the initial informed consent process.  
I have orally reviewed the contents of the consent document with the person who has signed 
above, and answered all of the person’s questions about the research. 
 
             
Person Obtaining Consent  (PRINT)                      Signature                                    Date   
 
 
             
Principal Investigator   (PRINT)                           Signature                                    Date   
(If other than person obtaining informed consent) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
